Document Detail


National review of first treatment change after starting highly active antiretroviral therapy in antiretroviral-naïve patients.
MedLine Citation:
PMID:  17461863     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: The aim of the study was to explore the factors surrounding modification of the first antiretroviral (ARV) regimen where drug switch occurred 3 months or more after initiation. Reference was made to the British HIV Association (BHIVA) guidelines on HIV management. METHODS: A case note and questionnaire-based audit was carried out. RESULTS: Toxicity was the single most important reason for ARV change and was the only, or a contributory, cause in over half the patients. Virological failure, adherence issues, requirement for treatment simplification, and patient request were other significant reasons cited. In one-third of those with virological failure, six or more months had elapsed between first detection and the time of switching to a new ARV regimen. CONCLUSIONS: This audit demonstrated broad adherence to the BHIVA guidelines, although the long time before switching ARVs in the setting of virological failure was of some concern, particularly given the continuing and significant occurrence of primary ARV resistance in the UK.
Authors:
E Hart; H Curtis; E Wilkins; M Johnson
Related Documents :
2445283 - Tolerance and antiviral effect of ribavirin in patients with argentine hemorrhagic fever.
8176573 - High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infa...
22655493 - The combined impact of postoperative heart failure and euroscore on long-term outcome a...
Publication Detail:
Type:  Journal Article; Multicenter Study    
Journal Detail:
Title:  HIV medicine     Volume:  8     ISSN:  1464-2662     ISO Abbreviation:  HIV Med.     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-04-27     Completed Date:  2007-12-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897392     Medline TA:  HIV Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  186-91     Citation Subset:  IM    
Affiliation:
North Manchester General Hospital, Manchester, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-HIV Agents / administration & dosage,  adverse effects
Antiretroviral Therapy, Highly Active / adverse effects,  methods*
Great Britain
HIV / growth & development*
HIV Infections / drug therapy*,  virology
Humans
Practice Guidelines as Topic
Viral Load
Chemical
Reg. No./Substance:
0/Anti-HIV Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Setting a minimum threshold CD4 count for initiation of highly active antiretroviral therapy in HIV-...
Next Document:  Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected ...